Research & Clinical Trials
Chemo-Carrying Gold Nanoparticles Tested on Mesothelioma
- by Daniel King
- Research & Clinical Trials
- Feb 12, 2019
Italian researchers have found early success using gold nanoparticles as a chemotherapy-delivery vehicle for mesothelioma. They are hopeful their discovery will lead to an improvement in mesothelioma…
Read More
Mesothelioma Immunotherapy Combination Gaining Momentum
- by Tim Povtak
- Research & Clinical Trials
- Feb 11, 2019
Recent studies from France and the Netherlands have shown patients with pleural mesothelioma can benefit significantly from a second-line immunotherapy drug combination. In separate phase II studies, the combination of…
Read More
Vaccine and Chemotherapy Combo Shows Promise for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Jan 22, 2019
Mesothelioma patients showed an impressive immune response to TroVax, a novel cancer vaccine, when it was combined with standard chemotherapy in a recent clinical trial. Researchers from Cardiff University in…
Read More
Top 10 Mesothelioma and Asbestos News Stories of 2018
- by Tim Povtak
- Research & Clinical Trials
- Dec 20, 2018
The death of renowned thoracic surgeon Dr. David Sugarbaker stunned the mesothelioma community, while asbestos awareness reached new heights in 2018. The loss of Sugarbaker, who pioneered mesothelioma treatment…
Read More
Clinical Trial Tests CAR T-Cell Therapy on Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Dec 18, 2018
The National Cancer Institute in Rockville, Maryland, has opened an innovative clinical trial for patients with peritoneal mesothelioma that will explore the safety and effectiveness of a novel CAR…
Read More
Cancer Incidence Rising Rapidly Around the World
- by Tim Povtak
- Research & Clinical Trials
- Dec 13, 2018
More than 30,000 people around the world will be diagnosed with malignant mesothelioma cancer in 2018, according to the latest estimates by the International Agency for Research on Cancer.
Read More
Study Shows Cancer Patients Can Benefit from Opioid Switching
- by Tim Povtak
- Research & Clinical Trials
- Nov 26, 2018
Switching from one prescription opioid to another often solves the problem of debilitating side effects or inadequate pain relief, according to a recent study involving a wide range of cancer…
Read More
Abramson Developing CAR T-Cell Therapy for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Nov 20, 2018
The National Cancer Institute awarded a five-year, $10.7 million grant to the Abramson Cancer Center at the University of Pennsylvania to develop CAR T-cell therapy for mesothelioma and lung…
Read More
Mesothelioma Patients Can Benefit from Genetic Testing
- by Tim Povtak
- Research & Clinical Trials
- Nov 13, 2018
All patients diagnosed with malignant mesothelioma should undergo genetic testing to better identify the most appropriate treatment plan, according to Dr. Michele Carbone, the director of thoracic oncology at…
Read More
French Study Reveals Potential Mesothelioma Treatment Target
- by Suzanne Dixon
- Research & Clinical Trials
- Oct 31, 2018
A team of French researchers led by Dr. Christophe Blanquart has identified a substance that may better define the severity of malignant pleural mesothelioma (MPM) in the body and…
Read More
